You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

Chlorothiazide - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for chlorothiazide and what is the scope of patent protection?

Chlorothiazide is the generic ingredient in eleven branded drugs marketed by Salix Pharms, Abc Holding, Hikma Intl Pharms, Lederle, Norvium Bioscience, Sandoz, Watson Labs, Rising, Am Regent, Fresenius Kabi Usa, Rk Pharma, Sagent Pharms Inc, Sun Pharm, Merck, Par Pharm, and Hikma, and is included in twenty-nine NDAs. Additional information is available in the individual branded drug profile pages.

There are forty-two drug master file entries for chlorothiazide. One supplier is listed for this compound.

Summary for chlorothiazide
Drug Prices for chlorothiazide

See drug prices for chlorothiazide

Recent Clinical Trials for chlorothiazide

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of VirginiaPhase 4
Vanderbilt UniversityPhase 4
National Heart, Lung, and Blood Institute (NHLBI)Phase 1

See all chlorothiazide clinical trials

Pharmacology for chlorothiazide
Drug ClassThiazide Diuretic
Physiological EffectIncreased Diuresis
Medical Subject Heading (MeSH) Categories for chlorothiazide
Anatomical Therapeutic Chemical (ATC) Classes for chlorothiazide

US Patents and Regulatory Information for chlorothiazide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs CHLOROTHIAZIDE chlorothiazide TABLET;ORAL 086796-001 Aug 15, 1983 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Rising DIURIL chlorothiazide TABLET;ORAL 011145-002 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Merck DIUPRES-250 chlorothiazide; reserpine TABLET;ORAL 011635-003 Aug 26, 1987 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Merck ALDOCLOR-150 chlorothiazide; methyldopa TABLET;ORAL 016016-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.